Gabapentin
- Product NDC
- 0615-7962
- 11-digit product format
- 006157962
- Labeler code
- 0615
- Product ID
- 0615-7962_95f621eb-2e7f-4c67-87b8-d29e2cd494df
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA078787
- Marketing category
- ANDA
- Marketing start
- 2008-01-31
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7962-05 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-c4c9-f424-e053-dadaa90a57ce | 78deed78-f0c1-4bec-b718-2dcd4d540d69 |
| 0615-7962-30 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-c4c9-f424-e053-dadaa90a57ce | 78deed78-f0c1-4bec-b718-2dcd4d540d69 |
| 0615-7962-39 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-c4c9-f424-e053-dadaa90a57ce | 78deed78-f0c1-4bec-b718-2dcd4d540d69 |
| 0615-7962-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c4c9-f424-e053-dadaa90a57ce | 78deed78-f0c1-4bec-b718-2dcd4d540d69 |
| 0615-7962-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c4c9-f424-e053-dadaa90a57ce | 78deed78-f0c1-4bec-b718-2dcd4d540d69 |
| 0615-7962-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c4c9-f424-e053-dadaa90a57ce | 78deed78-f0c1-4bec-b718-2dcd4d540d69 |